×
About 10,388 results

ALLMedicine™ Hydrocephalus Center

Research & Reviews  3,951 results

An eye on the future for defeating hydrocephalus, ciliary dyskinesia-related hydrocepha...
https://doi.org/10.1080/02688697.2022.2074373
British Journal of Neurosurgery; Hasanain AA, Soliman MAR et. al.

May 18th, 2022 - Congenital hydrocephalus affects approximately one in 1000 newborn children and is fatal in approximately 50% of untreated cases. The currently known management protocols usually necessitate multiple interventions and long-term use of healthcare r...

Discovering a new part of the phenotypic spectrum of Coffin-Siris syndrome in a fetal c...
https://doi.org/10.1016/j.gim.2022.04.010
Genetics in Medicine : Official Journal of the American C... van der Sluijs PJ, Joosten M et. al.

May 18th, 2022 - Genome-wide sequencing is increasingly being performed during pregnancy to identify the genetic cause of congenital anomalies. The interpretation of prenatally identified variants can be challenging and is hampered by our often limited knowledge o...

A new screening test for idiopathic normal pressure hydrocephalus using bimanual coordi...
https://doi.org/10.3233/NRE-220010
NeuroRehabilitation Umemori T, Higuchi T et. al.

May 17th, 2022 - The clinical spectrum of idiopathic normal pressure hydrocephalus (iNPH) comprises the triad of gait disturbance, cognitive impairment, and urinary incontinence. However, motor abnormalities involving the upper extremities in iNPH patients have fe...

see more →

Guidelines  10 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the...
https://doi.org/10.1093/neuros/nyz265
Neurosurgery Blount JP, Durham SR et. al.

Aug 17th, 2019 - Myelomeningocele (MM) is the most common congenital anomaly to affect the nervous system and affects 1500-2000 newborn infants per year in the United States. It is accompanied by symptomatic hydrocephalus in approximately 70%-80% of patients. Diff...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the...
https://doi.org/10.1093/neuros/nyz262
Neurosurgery Tamber MS, Flannery AM et. al.

Aug 17th, 2019 - Myelomeningocele (MM) is a condition that is responsible for considerable morbidity in the pediatric population. A significant proportion of the morbidity related to MM is attributable to hydrocephalus and the surgical management thereof. Postnata...

ACR Appropriateness Criteria® Acute Mental Status Change, Delirium, and New Onset Psych...
https://doi.org/10.1016/j.jacr.2019.02.024
Journal of the American College of Radiology : JACR; , Luttrull MD et. al.

May 6th, 2019 - Acute changes in mental status represent a broad collection of symptoms used to describe disorders in mentation and level of arousal, including the more narrowly defined diagnoses of delirium and psychosis. A wide range of precipitating factors ma...

Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Pa...
https://doi.org/10.3171/2014.7.PEDS14322
Journal of Neurosurgery. Pediatrics; Mazzola CA, Choudhri AF et. al.

May 20th, 2015 - The objective of this systematic review and analysis was to answer the following question: What are the optimal treatment strategies for posthemorrhagic hydrocephalus (PHH) in premature infants? Both the US National Library of Medicine and the Coc...

Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Pa...
https://doi.org/10.3171/2014.7.PEDS14323
Journal of Neurosurgery. Pediatrics; Flannery AM, Duhaime AC et. al.

May 20th, 2015 - This systematic review was undertaken to answer the following question: Do technical adjuvants such as ventricular endoscopic placement, computer-assisted electromagnetic guidance, or ultrasound guidance improve ventricular shunt function and surv...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  73 results

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies
https://clinicaltrials.gov/ct2/show/NCT04020198

May 5th, 2022 - This is an observational study looking at clinical and biomarker characteristics in patients with Parkinson's disease (PD), Multiple System Atrophy (MSA), Rapid Eye Movement Sleep Behavior Disorder (RBD), Normal Pressure Hydrocephalus (NPH) and ma...

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
https://clinicaltrials.gov/ct2/show/NCT05232838

Apr 28th, 2022 - This is a prospective, non-randomized, open-label, multi-center, pilot study in subjects with normal pressure hydrocephalus for whom a traditional cerebrospinal fluid (CSF) shunt implant is indicated. Up to 10 subjects will receive the eShunt Impl...

External Ventricular Drain Placement Stealth Study
https://clinicaltrials.gov/ct2/show/NCT03696043

Apr 6th, 2022 - External ventricular drain (EVD) placement is performed very often in neurosurgical practices. EVD's are used most commonly to monitor intracranial pressure and divert cerebrospinal fluid (CSF) in patients with increased intracranial pressures. Pa...

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study
https://clinicaltrials.gov/ct2/show/NCT03794011

Apr 5th, 2022 - Spina bifida can be a devastating neurological congenital anomaly. It results from incomplete closure of the neural tube between 22 and 28 embryological days. Its incidence is approximately 1-2 per 1,000 births. It is considered the most common co...

Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
https://clinicaltrials.gov/ct2/show/NCT05250505

Mar 25th, 2022 - This is a prospective, non-randomized, open-label, single-center, pilot study in subjects with normal pressure hydrocephalus for whom a traditional CSF shunt implant is indicated. Up to 30 subjects will receive the eShunt Implant at one investigat...

see more →

News  109 results

GD2-Directed CAR T-Cell Therapy Elicits Durable Benefit in H3K27M-Mutated Diffuse Intrinsic Pontine Gliomas
https://www.onclive.com/view/gd2-directed-car-t-cell-therapy-elicits-durable-benefit-in-h3k27m-mutated-diffuse-intrinsic-pontine-gliomas

May 2nd, 2022 - GD2-directed CAR T-cell therapy (GD2-CART) demonstrated prolonged periods of radiographic and clinical improvement in pediatric and young adult patients with H3K27M-mutated diffuse intrinsic pontine gliomas (DIPG) and spinal diffuse midline glioma...

Folic Acid Being Added to Some Flour 
https://www.medscape.com/viewarticle/959047

Sep 20th, 2021 - Folic acid is to be added to non-wholemeal wheat flour across the UK to help reduce neural tube defects in babies by around 20%, or 200 cases a year. The decision follows a consultation in 2019 and is based on evidence of successful fortification ...

First Trimester Use of Macrolide Antibiotics and Risk of Congenital Anomaly
https://www.medscape.com/viewarticle/944995

Feb 2nd, 2021 - Takeaway First trimester use of macrolide antibiotics (mainly erythromycin, spiramycin, clarithromycin and azithromycin) was not associated with an increased risk of congenital heart defects (CHDs) as a whole. Erythromycin, clarithromycin and azit...

Certifying Medical Cannabis: What APRNs Need to Know
https://www.medscape.com/viewarticle/943249

Jan 5th, 2021 - A patient asks an advanced practice registered nurse (APRN) to approve them for "medical marijuana." What are the clinician's responsibilities? The first hurdle is legal. In 18 states, an APRN has the legal authority to certify a patient to use ma...

Atezolizumab Plus Vemurafenib/Cobimetinib Impresses in BRAF V600+ Melanoma
https://www.onclive.com/view/atezolizumab-plus-vemurafenib-cobimetinib-impresses-in-braf-v600-melanoma

Dec 20th, 2020 - Grant A. McArthur, MBBS, PhD Treatment with atezolizumab (Tecentriq) in combination with vemurafenib (Zelboraf) and cobimetinib (Cotellic) was found to significantly improve progression-free survival (PFS) and produce durable responses versus vem...

see more →

Patient Education  11 results see all →